• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒负链内部核糖体进入位点结构域I特异性RNA适配体的分离与鉴定

Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.

作者信息

Konno Keisuke, Fujita Syusuke, Iizuka Mana, Nishikawa Satoshi, Hasegawa Tsunemi, Fukuda Kotaro

机构信息

Department of Material and Biological Chemistry, Faculty of Science, Yamagata University, Yamagata 990-8560, Japan.

出版信息

Nucleic Acids Symp Ser (Oxf). 2008(52):493-4. doi: 10.1093/nass/nrn250.

DOI:10.1093/nass/nrn250
PMID:18776469
Abstract

The minus-IRES ((-)IRES), corresponding to the 3'-terminal end of the negative strand of hepatitis C virus (HCV) RNA, is well conserved among HCV subtypes. The higher order structure of (-)IRES is essential for HCV replication, because the viral RNA dependent RNA polymerase, NS5B, recognizes it as the initiation site for plus-strand synthesis of the HCV genome. To inhibit the "de novo" synthesis of plus-strand RNA molecules, we performed an in vitro selection procedure for RNA aptamers that are specific for (-)IRES domain I. Among the selected aptamers, one RNA aptamer had two binding sites for the (-)IRES domain I. We found that this aptamer inhibited plus-strand synthesis by about 50%, suggesting that both binding sites are important for binding to its target within the (-)IRES domain I.

摘要

负内部核糖体进入位点((-)IRES)对应于丙型肝炎病毒(HCV)RNA负链的3'末端,在HCV各亚型中高度保守。(-)IRES的高级结构对于HCV复制至关重要,因为病毒RNA依赖性RNA聚合酶NS5B将其识别为HCV基因组正链合成的起始位点。为了抑制正链RNA分子的“从头”合成,我们针对(-)IRES结构域I进行了RNA适体的体外筛选程序。在筛选出的适体中,一种RNA适体对(-)IRES结构域I有两个结合位点。我们发现这种适体可将正链合成抑制约50%,这表明两个结合位点对于在(-)IRES结构域I内与其靶标结合都很重要。

相似文献

1
Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.丙型肝炎病毒负链内部核糖体进入位点结构域I特异性RNA适配体的分离与鉴定
Nucleic Acids Symp Ser (Oxf). 2008(52):493-4. doi: 10.1093/nass/nrn250.
2
Isolation of RNA aptamers specific for the HCV minus-IRES domain I.丙型肝炎病毒负链内部核糖体进入位点结构域I特异性RNA适配体的分离
Nucleic Acids Symp Ser (Oxf). 2007(51):393-4. doi: 10.1093/nass/nrm197.
3
Isolation of RNA aptamers specific for the 3' X tail of HCV.丙型肝炎病毒(HCV)3' X尾特异性RNA适配体的分离
Nucleic Acids Symp Ser (Oxf). 2008(52):205-6. doi: 10.1093/nass/nrn104.
4
Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.共轭RNA适配体对丙型肝炎病毒内部核糖体进入位点的抑制能力增强。
Biochem Biophys Res Commun. 2009 Aug 14;386(1):118-23. doi: 10.1016/j.bbrc.2009.05.135. Epub 2009 Jun 6.
5
A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId.一种靶向丙型肝炎病毒(HCV)内部核糖体进入位点(IRES)结构域III-IV的适体通过与结构域IIId的一个顶端环结合来抑制翻译。
Nucleic Acids Res. 2005 Jan 28;33(2):683-92. doi: 10.1093/nar/gki215. Print 2005.
6
Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA.不均一核核糖核蛋白I(hnRNP-I/PTB)选择性结合丙型肝炎病毒RNA的保守3'末端。
Biochem Biophys Res Commun. 1999 Jan 19;254(2):351-62. doi: 10.1006/bbrc.1998.9949.
7
hnRNP L is required for the translation mediated by HCV IRES.丙型肝炎病毒内部核糖体进入位点介导的翻译需要hnRNP L。
Biochem Biophys Res Commun. 2009 Jan 16;378(3):584-8. doi: 10.1016/j.bbrc.2008.11.091. Epub 2008 Dec 4.
8
Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.利用一种新型体外筛选方法鉴定出的RNA分子干扰丙型肝炎病毒内部核糖体进入位点(IRES)活性。
Biol Chem. 2005 Feb;386(2):183-90. doi: 10.1515/BC.2005.023.
9
An RNA aptamer containing two binding sites against the HCV minus-IRES domain I.
Nucleosides Nucleotides Nucleic Acids. 2011 Mar;30(3):185-202. doi: 10.1080/15257770.2011.562475.
10
Determinants of apical loop-internal loop RNA-RNA interactions involving the HCV IRES.涉及丙型肝炎病毒内部核糖体进入位点的顶端环-内部环RNA-RNA相互作用的决定因素
Biochem Biophys Res Commun. 2004 Sep 24;322(3):820-6. doi: 10.1016/j.bbrc.2004.07.185.

引用本文的文献

1
Aptamers for Viral Detection and Inhibition.适体在病毒检测和抑制中的应用。
ACS Infect Dis. 2022 Apr 8;8(4):667-692. doi: 10.1021/acsinfecdis.1c00546. Epub 2022 Feb 27.
2
Aptamers for Anti-Viral Therapeutics and Diagnostics.适体在抗病毒治疗和诊断中的应用
Int J Mol Sci. 2021 Apr 17;22(8):4168. doi: 10.3390/ijms22084168.
3
Oligonucleotide aptamers: potential novel molecules against viral hepatitis.寡核苷酸适配体:对抗病毒性肝炎的潜在新型分子。
Res Pharm Sci. 2017 Apr;12(2):88-98. doi: 10.4103/1735-5362.202447.
4
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.适体作为人类病毒诊断工具和抗病毒剂的应用。
Pharmaceuticals (Basel). 2016 Dec 16;9(4):78. doi: 10.3390/ph9040078.
5
Aptamers in Therapeutics.治疗学中的适配体。
J Clin Diagn Res. 2016 Jun;10(6):BE01-6. doi: 10.7860/JCDR/2016/18712.7922. Epub 2016 Jun 1.
6
Aptamers in diagnostics and treatment of viral infections.适体在病毒感染诊断与治疗中的应用
Viruses. 2015 Feb 16;7(2):751-80. doi: 10.3390/v7020751.
7
Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site.丙型肝炎病毒翻译抑制剂靶向内部核糖体进入位点。
J Med Chem. 2014 Mar 13;57(5):1694-707. doi: 10.1021/jm401312n. Epub 2013 Nov 5.
8
Oligomeric nucleic acids as antivirals.寡核苷酸作为抗病毒药物。
Molecules. 2011 Jan 28;16(2):1271-96. doi: 10.3390/molecules16021271.
9
In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules.体外和离体选择程序,用于鉴定有潜在治疗作用的 DNA 和 RNA 分子。
Molecules. 2010 Jun 28;15(7):4610-38. doi: 10.3390/molecules15074610.
10
Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.单链 RNA 结构模拟物抑制丙型肝炎病毒复制。
World J Gastroenterol. 2010 May 7;16(17):2100-8. doi: 10.3748/wjg.v16.i17.2100.